Phase 1 Study of Safety, Tolerability, and Pharmacokinetics of PTC299, an Inhibitor of Stress-Regulated Protein Translation
应激调节蛋白翻译抑制剂 PTC299 的安全性、耐受性和药代动力学 1 期研究
期刊:Clinical Pharmacology in Drug Development
影响因子:1.5
doi:10.1002/cpdd.240
Marla Weetall, Thomas Davis, Gary Elfring, Valerie Northcutt, Liangxian Cao, Young-Choon Moon, Peter Riebling, Mandar Dali, Samit Hirawat, John Babiak, Joseph Colacino, Neil Almstead, Robert Spiegel, Stuart W Peltz
